Role of PAF and cytokines in microvascular tissue injury.
Koltai
M
M
Institut Henri Beaufour, Le Plessis Robinson, France.
Hosford
D
D
Braquet
P
P
D002448:Cell Adhesion; D002465:Cell Movement; D016207:Cytokines / Q000494:pharmacology; D004224:Diterpenes; D046934:Ginkgolides; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D007783:Lactones / Q000494:pharmacology; D008833:Microcirculation / Q000187:drug effects; D009504:Neutrophils / Q000166:cytology*; D010972:Platelet Activating Factor / Q000502:physiology*; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000187:drug effects; D043562:Receptors, G-Protein-Coupled; D012772:Shock, Septic / Q000503:physiopathology* / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016207:Cytokines; D004224:Diterpenes; D046934:Ginkgolides; D007375:Interleukin-1; D007376:Interleukin-2; D007783:Lactones; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D014409:Tumor Necrosis Factor-alpha; C039351:platelet activating factor receptor; C045856:ginkgolide B